| 1 |
28117675 | F-Box Protein FBXO22 Mediates Polyubiquitination and Degradation of CD147 to Reverse Cisplatin Resistance of Tumor Cells. | 2017 Jan 20 |
3 |
| 2 |
25263481 | CD147 and MCT1-potential partners in bladder cancer aggressiveness and cisplatin resistance. | 2015 Nov |
4 |
| 3 |
25704985 | Dynamic contrast-enhanced MRI evaluates the early response of human head and neck tumor xenografts following anti-EMMPRIN therapy with cisplatin or irradiation. | 2015 Oct |
1 |
| 4 |
26119672 | Emmprin Expression Predicts Response and Survival following Cisplatin Containing Chemotherapy for Bladder Cancer: A Validation Study. | 2015 Dec |
1 |
| 5 |
26316167 | Inhibition of CD147 expression by RNA interference reduces proliferation, invasion and increases chemosensitivity in cancer stem cell-like HT-29 cells. | 2015 Oct |
1 |
| 6 |
23413783 | Overexpression of CD147 contributes to the chemoresistance of head and neck squamous cell carcinoma cells. | 2013 Aug |
7 |
| 7 |
21745000 | Expression of CD147 in advanced non-small cell lung cancer correlated with cisplatin-based chemotherapy resistance. | 2011 |
6 |
| 8 |
20525232 | RNAi-mediated silencing of CD147 inhibits tumor cell proliferation, invasion and increases chemosensitivity to cisplatin in SGC7901 cells in vitro. | 2010 Jun 3 |
2 |
| 9 |
17611393 | Bridge linkage role played by CD98hc of anti-tumor drug resistance and cancer metastasis on cisplatin-resistant ovarian cancer cells. | 2007 Jun |
2 |
| 10 |
17671123 | Emmprin and survivin predict response and survival following cisplatin-containing chemotherapy in patients with advanced bladder cancer. | 2007 Aug 1 |
2 |